RecBio

company

About

Focusing on major innovative vaccines with independent intellectual property rights.

Details

Last Funding Type
Series B
Last Funding Money Raised
¥1.50B
Industries
Health Care,Life Science
Founded date
Jan 1, 2012
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥1.50B
RecBio has raised a total of ¥1.50B in funding over 2 rounds. Their latest funding was raised on Nov 11, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 11, 2020 Series B ¥1.50B 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
RecBio is funded by 2 investors. HT Capital and China Everbright Investment Management are the most recent investors.
Investor Name Lead Investor Funding Round
HT Capital Series B
China Everbright Investment Management Series B